New therapeutic targets and strategies in lung cancer

Saved in:
Bibliographic Details
Published in:Archivos de bronconeumología 2002-08, Vol.38 (8), p.386-391
Main Author: Sánchez De Cos Escuín, J
Format: Article
Language:Spanish
Subjects:
Alkyl and Aryl Transferases - antagonists & inhibitors
Angiogenesis Inhibitors - therapeutic use
Antineoplastic Agents - therapeutic use
Benzamides
Benzodiazepines - therapeutic use
Clinical Trials as Topic
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Endothelial Growth Factors - antagonists & inhibitors
Endothelial Growth Factors - immunology
Enzyme Inhibitors - therapeutic use
Epidermal Growth Factor - antagonists & inhibitors
ErbB Receptors - antagonists & inhibitors
Erlotinib Hydrochloride
Farnesyltranstransferase
Gefitinib
Humans
Imatinib Mesylate
Imidazoles - therapeutic use
Intercellular Signaling Peptides and Proteins - immunology
Lung Neoplasms - drug therapy
Lymphokines - antagonists & inhibitors
Lymphokines - immunology
Metalloendopeptidases - antagonists & inhibitors
Multicenter Studies as Topic
Piperazines
Polyisoprenyl Phosphates - metabolism
Protein-Tyrosine Kinases - antagonists & inhibitors
Pyrimidines - therapeutic use
Quinazolines - therapeutic use
Quinolones - therapeutic use
Randomized Controlled Trials as Topic
Receptor Protein-Tyrosine Kinases - antagonists & inhibitors
Sesquiterpenes
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0300-2896
DOI:10.1016/S0300-2896(02)75244-7